Q2 2025 · 1 tracked holders Snapshot · 16 Nov 2026 Export CSV
Security file · CUSIP 02043QAB3

ALNYLAM PHARMACEUTICALS INC

ALNYLAM PHARMACEUTICALS INC · held by 1 tracked manager in Q2 2025.

Tracked holders · Q2 2025
1
+0 vs Q4 2024
Aggregate reported value
$976K
sum of holders' reported positions
New holders this quarter
0
0 added · 1 trimmed
Holder return since filing
—
weighted by each holder's position share · since filing
Ownership · Q2 2025
ManagerWeight SharesΔ shares Entry Return ValueActivity
1 Howard Marks - Oaktree Capital Managementfiled 13 Aug ET 0.02% 750K -44.4% — — $976K Trimmed
Holder count
Q3 2023Q4 2023Q3 2024Q4 2024Q2 20251
Aggregate reported value
Q3 2023Q4 2023Q3 2024Q4 2024Q2 2025$2.47M
Quarterly aggregation
QuarterHoldersΔ holdersAggregate valueTotal shares
Q2 2025 1 +0 $976K 750K
Q4 2024 1 +0 $1.44M 1.35M
Q3 2024 1 +0 $2.11M 1.80M
Q4 2023 1 +0 $2.47M 2.50M
Q3 2023 1 — $2.32M 2.50M